Figure 2From: Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/mlFour-year biochemical relapse-free survival in patients with pT3-4 and that in patients with pT1-2.Back to article page